| Kara Grace Hibbitt, APRN | |
|
220 Westwood St, Glasgow, KY 42141-1028 | |
| (270) 651-3499 | |
| Not Available |
| Full Name | Kara Grace Hibbitt |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 7 Years |
| Location | 220 Westwood St, Glasgow, Kentucky |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295233435 | NPI | - | NPPES |
| 3012003 | Other | KY | APRN LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 3012003 (Kentucky) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Shc Medical Partners Of Kentucky, Llc | 1153406301 | 36 |
| Abode Care Partners Ltc Vb, Llc | 8325316516 | 43 |
News Archive
Chronic liver disease and even cirrhosis can go unnoticed for a long time because many patients have no symptoms: the liver suffers silently.
A pair of Scripps Research Institute scientists, one a cancer biologist and the other a chemist, has been awarded $3.85 million from the National Institutes of Health (NIH) to develop a new generation of broad spectrum anti-cancer therapeutics, including breast cancer and lymphoma.
Although calcium supplements might prevent development of polyps that sometimes lead to colon cancer, there is not enough evidence that the mineral can prevent colorectal cancer itself, according to a new study.
Northwestern Medicine and University of Wisconsin-Madison scientists have identified a gene that causes severe glaucoma in children.
Today, Formatech, Inc. announces the selection of Tracon Pharmaceuticals' TRC102 clinical product as the next Fillanthropy™ Program candidate. Under this program, Formatech donates the services required to aseptically fill and finish one lot of the drug candidate to support Tracon's upcoming clinical trials.
› Verified 6 days ago
| Entity Name | Cogent Healthcare Of Kentucky, Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053362293 PECOS PAC ID: 0648294157 Enrollment ID: O20060124000434 |
News Archive
Chronic liver disease and even cirrhosis can go unnoticed for a long time because many patients have no symptoms: the liver suffers silently.
A pair of Scripps Research Institute scientists, one a cancer biologist and the other a chemist, has been awarded $3.85 million from the National Institutes of Health (NIH) to develop a new generation of broad spectrum anti-cancer therapeutics, including breast cancer and lymphoma.
Although calcium supplements might prevent development of polyps that sometimes lead to colon cancer, there is not enough evidence that the mineral can prevent colorectal cancer itself, according to a new study.
Northwestern Medicine and University of Wisconsin-Madison scientists have identified a gene that causes severe glaucoma in children.
Today, Formatech, Inc. announces the selection of Tracon Pharmaceuticals' TRC102 clinical product as the next Fillanthropy™ Program candidate. Under this program, Formatech donates the services required to aseptically fill and finish one lot of the drug candidate to support Tracon's upcoming clinical trials.
› Verified 6 days ago
| Entity Name | Shc Medical Partners Of Kentucky, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417132614 PECOS PAC ID: 1153406301 Enrollment ID: O20080312000024 |
News Archive
Chronic liver disease and even cirrhosis can go unnoticed for a long time because many patients have no symptoms: the liver suffers silently.
A pair of Scripps Research Institute scientists, one a cancer biologist and the other a chemist, has been awarded $3.85 million from the National Institutes of Health (NIH) to develop a new generation of broad spectrum anti-cancer therapeutics, including breast cancer and lymphoma.
Although calcium supplements might prevent development of polyps that sometimes lead to colon cancer, there is not enough evidence that the mineral can prevent colorectal cancer itself, according to a new study.
Northwestern Medicine and University of Wisconsin-Madison scientists have identified a gene that causes severe glaucoma in children.
Today, Formatech, Inc. announces the selection of Tracon Pharmaceuticals' TRC102 clinical product as the next Fillanthropy™ Program candidate. Under this program, Formatech donates the services required to aseptically fill and finish one lot of the drug candidate to support Tracon's upcoming clinical trials.
› Verified 6 days ago
| Entity Name | Signify Health Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689158487 PECOS PAC ID: 3274895263 Enrollment ID: O20210209002652 |
News Archive
Chronic liver disease and even cirrhosis can go unnoticed for a long time because many patients have no symptoms: the liver suffers silently.
A pair of Scripps Research Institute scientists, one a cancer biologist and the other a chemist, has been awarded $3.85 million from the National Institutes of Health (NIH) to develop a new generation of broad spectrum anti-cancer therapeutics, including breast cancer and lymphoma.
Although calcium supplements might prevent development of polyps that sometimes lead to colon cancer, there is not enough evidence that the mineral can prevent colorectal cancer itself, according to a new study.
Northwestern Medicine and University of Wisconsin-Madison scientists have identified a gene that causes severe glaucoma in children.
Today, Formatech, Inc. announces the selection of Tracon Pharmaceuticals' TRC102 clinical product as the next Fillanthropy™ Program candidate. Under this program, Formatech donates the services required to aseptically fill and finish one lot of the drug candidate to support Tracon's upcoming clinical trials.
› Verified 6 days ago
| Entity Name | Abode Care Partners Ltc Vb, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447029798 PECOS PAC ID: 8325316516 Enrollment ID: O20240124001005 |
News Archive
Chronic liver disease and even cirrhosis can go unnoticed for a long time because many patients have no symptoms: the liver suffers silently.
A pair of Scripps Research Institute scientists, one a cancer biologist and the other a chemist, has been awarded $3.85 million from the National Institutes of Health (NIH) to develop a new generation of broad spectrum anti-cancer therapeutics, including breast cancer and lymphoma.
Although calcium supplements might prevent development of polyps that sometimes lead to colon cancer, there is not enough evidence that the mineral can prevent colorectal cancer itself, according to a new study.
Northwestern Medicine and University of Wisconsin-Madison scientists have identified a gene that causes severe glaucoma in children.
Today, Formatech, Inc. announces the selection of Tracon Pharmaceuticals' TRC102 clinical product as the next Fillanthropy™ Program candidate. Under this program, Formatech donates the services required to aseptically fill and finish one lot of the drug candidate to support Tracon's upcoming clinical trials.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kara Grace Hibbitt, APRN 12201 Bluegrass Pkwy, Louisville, KY 40299-2361 Ph: (502) 568-7364 | Kara Grace Hibbitt, APRN 220 Westwood St, Glasgow, KY 42141-1028 Ph: (270) 651-3499 |
News Archive
Chronic liver disease and even cirrhosis can go unnoticed for a long time because many patients have no symptoms: the liver suffers silently.
A pair of Scripps Research Institute scientists, one a cancer biologist and the other a chemist, has been awarded $3.85 million from the National Institutes of Health (NIH) to develop a new generation of broad spectrum anti-cancer therapeutics, including breast cancer and lymphoma.
Although calcium supplements might prevent development of polyps that sometimes lead to colon cancer, there is not enough evidence that the mineral can prevent colorectal cancer itself, according to a new study.
Northwestern Medicine and University of Wisconsin-Madison scientists have identified a gene that causes severe glaucoma in children.
Today, Formatech, Inc. announces the selection of Tracon Pharmaceuticals' TRC102 clinical product as the next Fillanthropy™ Program candidate. Under this program, Formatech donates the services required to aseptically fill and finish one lot of the drug candidate to support Tracon's upcoming clinical trials.
› Verified 6 days ago
Mr. James Isenberg, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 201 Professional Park Dr, Glasgow, KY 42141 Phone: 270-392-3661 Fax: 580-297-9310 | |
Mrs. Britney M. Jackson, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 102 Physicians Blvd Ste B, Glasgow, KY 42141 Phone: 270-629-6722 Fax: 270-629-6723 | |
Taryn Alycia Conrad, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1301 N Race St, Glasgow, KY 42141 Phone: 270-651-4444 | |
Mrs. Beverly Jo Mortimer, ARNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1330 N Race St, Glasgow, KY 42141 Phone: 270-629-5111 Fax: 270-783-3760 | |
Mr. Michael L Pendleton Sr., APRN Nurse Practitioner Medicare: May Accept Medicare Assignments Practice Location: 1412 N Race St, Glasgow, KY 42141 Phone: 270-629-6333 Fax: 270-629-6334 | |
Tarah Jo Mathews, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 100 S Broadway St, Glasgow, KY 42141 Phone: 270-861-0606 Fax: 270-629-2444 | |
Mrs. Kimberly A Bowman, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1301 N Race St, Glasgow, KY 42141 Phone: 270-651-1888 Fax: 270-651-1889 |